I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Canakinumab with and without pembrolizumab in patients with..:
Garrido, Pilar
;
Pujol, Jean-Louis
;
Kim, Edward
...
info:eu-repo/semantics/altIdentifier/doi/10.2217/fon-2020-1098. , 2021
Link:
https://hal.science/hal-03657197
RT Journal T1
Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design
UL https://suche.suub.uni-bremen.de/peid=base-ftccsdartic:oai:HAL:hal-03657197v1&Exemplar=1&LAN=DE A1 Garrido, Pilar A1 Pujol, Jean-Louis A1 Kim, Edward A1 Lee, Jay A1 Tsuboi, Masahiro A1 Gómez-Rueda, Ana A1 Benito, Amparo A1 Moreno, Nicolas A1 Gorospe, Luis A1 Dong, Tuochuan A1 Blin, Cecile A1 Rodrik-Outmezguine, Vanessa A1 Passos, Vanessa A1 Mok, Tony Sk PB HAL CCSD; Future Medicine YR 2021 K1 CANOPY K1 MPR K1 canakinumab K1 early stage K1 immunotherapy K1 major pathological response K1 neoadjuvant K1 non-small-cell lung cancer K1 resection K1 surgery K1 MESH: Adolescent K1 MESH: Adult K1 MESH: Antibodies K1 Monoclonal K1 Humanized K1 MESH: Antineoplastic Combined Chemotherapy Protocols K1 MESH: Carcinoma K1 Non-Small-Cell Lung K1 MESH: Clinical Trials K1 Phase II as Topic K1 MESH: Female K1 MESH: Humans K1 MESH: Interleukin-1beta K1 MESH: Lung K1 MESH: Lung Neoplasms K1 MESH: Male K1 MESH: Neoadjuvant Therapy K1 MESH: Neoplasm Staging K1 MESH: Pneumonectomy K1 MESH: Programmed Cell Death 1 Receptor K1 MESH: Randomized Controlled Trials as Topic K1 MESH: Young Adult K1 [SDV]Life Sciences [q-bio] JF info:eu-repo/semantics/altIdentifier/doi/10.2217/fon-2020-1098 LK http://dx.doi.org/https://hal.science/hal-03657197 DO https://hal.science/hal-03657197 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)